Donation of $1.6 Million Gets Your Name on Cancer Drug, FT Says

Researchers at Uppsala University in Sweden are offering to name an experimental cancer drug after anyone who donates 1 million pounds ($1.6 million) to help fund its development, the Financial Times said.

Academics at the Swedish college are trying to raise 2 million pounds to pay for a clinical trial in as many as 20 people for the potential treatment of neuroendocrine cancer, the newspaper said, citing comments from the university.

Steve Jobs, Apple Inc.’s late co-founder, died of respiratory arrest caused by a pancreatic neuroendocrine tumor.

To contact the reporter on this story: Chris Spillane in London cspillane3@bloomberg.net.

To contact the editor responsible for this story: Andrew Blackman at ablackman@bloomberg.net.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.